Leftwich Scott 4
4 · Calidi Biotherapeutics, Inc. · Filed Aug 25, 2025
Insider Transaction Report
Form 4
Leftwich Scott
Director
Transactions
- Purchase
Common Stock
2025-08-21$2.00/sh+125,000$250,000→ 130,650 total - Purchase
Warrant (right to buy)
2025-08-21+125,000→ 125,000 totalExercise: $2.00From: 2025-08-21Exp: 2030-08-21→ Common stock (125,000 underlying)
Holdings
- 14,672(indirect: By LLC)
Common Stock
- 1,309(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]The common stock and warrants were acquired by the reporting person in a public offering conducted by the Issuer that was closed on August 21, 2025.
- [F2]Each common share was purchased with an accompanying warrant for a purchase price of $2.00 per share and accompanying warrant.
- [F3]The reporting person is the managing member of SECBL, LLC and WEBCL, LLC, as such the reporting person may be deemed to have beneficial ownership of the common stock held by SECBL, LLC and WEBCL, LLC.